• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管型血管加压素受体的人源cDNA的克隆、功能表达及组织分布

Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor.

作者信息

Hirasawa A, Shibata K, Kotosai K, Tsujimoto G

机构信息

Department of Molecular Cell Pharmacology, National Children's Medical Research Center, Tokyo, Japan.

出版信息

Biochem Biophys Res Commun. 1994 Aug 30;203(1):72-9. doi: 10.1006/bbrc.1994.2150.

DOI:10.1006/bbrc.1994.2150
PMID:8074728
Abstract

We have cloned a human vasopressin receptor from human mesenteric artery using RACE (Rapid Amplification of cDNA Ends) methods. The deduced amino acid sequence of the clone (HV-RACE) encodes a protein of 418 amino acids that showed a strong sequence homology to the previously cloned rat V1A vasopressin receptor. The [3H] arginine vasopressin (AVP) binding to HV-RACE expressed in COS-7 cells was potently inhibited by AVP (Ki = 2.9 nM). Interestingly, a new non-peptide "V1-selective" antagonist OPC-21268 exhibited markedly higher affinity for rat V1A receptor (Ki = 57 nM) rather than for HV-RACE (Ki = 56 microM). With the reverse-transcription polymerase chain reaction assay, we observed a large amount of HV-RACE transcripts in the mesenteric artery, while a small amount in a variety of other tissues. The data show that the clone HV-RACE encodes a human vascular-type vasopressin receptor cDNA.

摘要

我们使用cDNA末端快速扩增(RACE)方法从人肠系膜动脉中克隆了一种人血管加压素受体。该克隆(HV-RACE)推导的氨基酸序列编码一个由418个氨基酸组成的蛋白质,它与先前克隆的大鼠V1A血管加压素受体显示出很强的序列同源性。在COS-7细胞中表达的HV-RACE与[3H]精氨酸血管加压素(AVP)的结合被AVP强烈抑制(Ki = 2.9 nM)。有趣的是,一种新的非肽类“V1选择性”拮抗剂OPC-21268对大鼠V1A受体(Ki = 57 nM)的亲和力明显高于对HV-RACE(Ki = 56 μM)的亲和力。通过逆转录聚合酶链反应分析,我们在肠系膜动脉中观察到大量的HV-RACE转录本,而在其他多种组织中含量较少。数据表明,克隆HV-RACE编码一种人血管型血管加压素受体cDNA。

相似文献

1
Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor.血管型血管加压素受体的人源cDNA的克隆、功能表达及组织分布
Biochem Biophys Res Commun. 1994 Aug 30;203(1):72-9. doi: 10.1006/bbrc.1994.2150.
2
Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor.人α1C - 肾上腺素能受体cDNA的克隆、功能表达及组织分布
Biochem Biophys Res Commun. 1993 Sep 15;195(2):902-9. doi: 10.1006/bbrc.1993.2130.
3
Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues.大鼠V1b血管加压素受体的分子克隆与特性分析:其在垂体外组织中表达的证据
Biochem Biophys Res Commun. 1995 Jul 26;212(3):751-7. doi: 10.1006/bbrc.1995.2033.
4
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.编码人血管升压素V1a受体的cDNA的分子克隆、测序及功能表达
J Biol Chem. 1994 Feb 4;269(5):3304-10.
5
Cloning and expression of a human glucagon receptor.
Biochem Biophys Res Commun. 1994 Jan 14;198(1):328-34. doi: 10.1006/bbrc.1994.1046.
6
Molecular cloning and expression of a rat V1a arginine vasopressin receptor.大鼠V1a精氨酸加压素受体的分子克隆与表达
Nature. 1992 Apr 9;356(6369):523-6. doi: 10.1038/356523a0.
7
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.OPC - 41061,一种高效的人血管加压素V2受体拮抗剂:大鼠单次和多次口服给药后的药理学特性及利水作用
J Pharmacol Exp Ther. 1998 Dec;287(3):860-7.
8
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.血管加压素V2受体的克隆与特性分析及其与肾性尿崩症的可能联系。
Nature. 1992 May 28;357(6376):336-9. doi: 10.1038/357336a0.
9
A fully active nonglycosylated V2 vasopressin receptor.
Mol Pharmacol. 1996 Sep;50(3):467-73.
10
Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.人5-羟色胺2B受体的分子克隆、功能表达及mRNA组织分布
Mol Pharmacol. 1994 Aug;46(2):227-34.

引用本文的文献

1
The Biology of Vasopressin.血管加压素的生物学
Biomedicines. 2021 Jan 18;9(1):89. doi: 10.3390/biomedicines9010089.
2
Hepatorenal Syndrome.肝肾综合征
Int J Clin Med. 2014 Jan;5(3):102-110. doi: 10.4236/ijcm.2014.53018.
3
Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells.大鼠游离脂肪酸受体GPR120的克隆与特性分析:天然配体对胰高血糖素样肽-1分泌及胰岛β细胞增殖的体内效应
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):515-22. doi: 10.1007/s00210-007-0250-y. Epub 2008 Mar 5.
4
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.d[Cha4]AVP和SSR149415对人血管加压素和催产素受体的选择性:SSR149415是一种血管加压素V1b/催产素受体混合型拮抗剂的证据。
Br J Pharmacol. 2005 Nov;146(5):744-51. doi: 10.1038/sj.bjp.0706383.
5
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.加压素V1b受体在应激和静息状态下均对下丘脑-垂体-肾上腺轴活动起关键调节作用。
J Clin Invest. 2004 Jan;113(2):302-9. doi: 10.1172/JCI19656.
6
Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.新型非肽类血管加压素V(2)激动剂OPC-51803在转染人血管加压素受体亚型的细胞中的特性研究
Br J Pharmacol. 2000 Apr;129(8):1700-6. doi: 10.1038/sj.bjp.0703221.
7
Protective effect of a vasopressin-1 selective antagonist, OPC-21268, against ethanol-induced damage of the rat gastric wall.
Dig Dis Sci. 1999 Mar;44(3):503-9. doi: 10.1023/a:1026640904010.
8
Oxytocin receptors expressed and coupled to Ca2+ signalling in a human vascular smooth muscle cell line.催产素受体在人血管平滑肌细胞系中表达并与钙离子信号传导偶联。
Br J Pharmacol. 1996 Mar;117(5):799-804. doi: 10.1111/j.1476-5381.1996.tb15263.x.
9
Axotomized neonatal motoneurons overexpressing the bcl2 proto-oncogene retain functional electrophysiological properties.过度表达bcl2原癌基因的新生轴突切断运动神经元保留了功能性电生理特性。
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3978-83. doi: 10.1073/pnas.93.9.3978.